Drug related problems after discharge from an Australian teaching hospital
- 593 Downloads
Objective To reconcile patients’ medicines and to classify drug related problems identified during medication review conducted after discharge from hospital. Setting Patients were discharged from the cardiology unit of Westmead Hospital after recruitment into the Westmead Medicines Project which ran from 2004 to 2007. Method This retrospective study involved an analysis of drugs, diseases and drug related problems in medication review reports available for 76 out of 85 patients who received a Home Medicines Review (HMR). Data sources for medication reconciliation and analyses also included hospital discharge summaries (n = 70) and GP referrals for HMR (n = 44). Comprehensive clinical profiles were constructed for the 76 subjects whose drug related problems were identified, coded, and then classified from their HMR reports. Main outcome measures Number, type, distribution and international classification of drugs, diseases and drug-related problems. Results Patients were prescribed drugs for a broad range of cardiovascular, circulatory, endocrine, respiratory and digestive system diseases. Mean number of drugs per patient in discharge summaries: 8.7 ± SD 3.3 (range 3–19); in GP referrals: 8.9 ± SD 4.3 (range 2–23); and in HMR reports: 10.8 ± SD 4.0 (range 3–24). Mean number of diseases per patient in discharge summaries: 4.1 ± SD 2.9 (range 1–11); and in HMR reports: 4.7 ± SD 2.6 (range 1–12). A total of 398 drug related problems were identified for 71 (93.3%) patients with mean 5.6 ± SD 4.3 problems (range 1–21). The most frequently recorded problems were the patients’ uncertainty about drug aim: n = 128 (32.0%); potential interactions n = 89 (22.4%); and adverse reactions n = 60 (15.1%). Conclusion This study showed that patients recently discharged from a tertiary care hospital had a significant number of drug related problems. Classification of drugs and diseases revealed a broad range of non-cardiovascular medicines and conditions in the patients from an acute care cardiology unit. We found that home medicines review provided continuity of care and an opportunity for medication reconciliation which revealed marked differences in number of drugs, between hospital discharge and medicines review. The patients’ uncertainly about their drugs and their diverse range of co-morbidities indicated the need for timely counselling by pharmacists in the community.
KeywordsAustralia Cardiovascular Continuity of care Drug related problems Medication reconciliation Medication review
The authors would like to thank Mr Kingsley Ng and Ms Elizabeth Anderson from the Department of Pharmacy, Westmead Hospital, Sydney West Area Health Service, NSW Australia, for their commitment in reviewing the HMR reports submitted to the research team.
The original research project was externally funded as part of the Research and Development Program, Third Community Pharmacy Agreement, managed by the Pharmacy Guild of Australia, and funded by the Australian Government Department of Health and Ageing.
Conflict of interest
The authors have no conflict of interest to declare.
- 7.Fekete EM, Antoni MH, Schneiderman N. Psychosocial and behavioural interventions for chronic medical conditions. Curr Opin Psychiatry. 2007;20:152–57. doi.org/ 10.1097/YCO.0b013e3280147724.
- 9.Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Social networks and partner stress as predictors of adherence to medication, rehabilitation attendance, and quality of life following acute coronary syndrome. Health Psychol. 2008;27:52–8. http://dx.doi.org/10.1037/0278-618.104.22.168. Accessed 17 Apr 2009.
- 15.Australian Government Medicare Australia. Home medicines review (HMR). http://www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp#N1007B (2009). Accessed 30 Jun 2009.
- 17.Pharmacy Guild of Australia. Quality use of medicines (QUM) collaborative report. 2007. http://www.guild.org.au/uploadedfiles/Medication_Management_Reviews/Overview/QUM_Collaborative_report.doc (2009). Accessed 14 Jun 2009.
- 19.Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. [see comment]. Ann Pharmacother. 2003;37:1186–93. doi.org/ 10.1345/aph.1C267.
- 20.Northern Health and Social Services Board PrescribingAdvisors. A guide to patient medication review. 2003. http://www.nhssb.n-i.nhs.uk/prescribing/documents/Guide.pdf (2009). Accessed 29 Jun 2009.
- 21.Westerlund LOT, Björk HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162–9. http://dx.doi.org/10.1345/aph.1G680. Accessed 17 Apr 2009.
- 22.Chen TF, Brien JE, Whitehead P, Ng K, Ellitt GR. From hospital to community: a multidisciplinary “continuity of care” model for cardiovascular patients involving community pharmacists. Funded projects, Research and Development Grants Program 2005. http://www.guild.org.au/research/funded_projects.asp (2009). Accessed 24 Jun 2009.
- 23.Pharmacy Guild of Australia. Home medicines review and medication management review. 2008. http://www.guild.org.au/mmr (2009). Accessed 14 Jun 2009.
- 24.van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. [see comment]. Ann Pharmacother. 2004;38:859–67. http://dx.doi.org/10.1345/aph.1D182. Accessed 17 Apr 2009.
- 25.Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40–50.Google Scholar
- 26.World Health Organisation. International classification of diseases version 10 (ICD-10). http://www.who.int/classifications/icd/en (2009). Accessed 2 Jul 2009.
- 27.World Health Organisation. The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). http://www.who.int/classifications/atcdd/en (2009). Accessed 1 Jul 2009.
- 29.Vinks TJAM, deKoning FHP, deLange TM, Egberts TCG. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci. 2006;28:33–38. http://dx.doi.org/10.1007/s11096-005-4213-4. Accessed 17 Apr 2009.
- 32.Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. [erratum appears in Br J Clin Pharmacol. 2005;59(3):376]. Br J Clin Pharmacol. 2004;58:648–64. http://dx.doi.org/10.1111/j.1365-2125.2004.02220.x. Accessed 17 Apr 2009.
- 34.Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig. 2006;26:415–25. http://dx.doi.org/10.2165/00044011-200626070-00003. Accessed 17 Apr 2009.